Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Ganoderic acid A is a bioactive triterpene compound extracted from Reishi mushrooms that exhibits potent hepatoprotective and immunomodulatory properties. This compound works primarily through NF-κB pathway inhibition and cytokine regulation to reduce inflammation and support liver function.
Reported Benefits (Provisional)
Origin & History
Ganoderic Acid A is a triterpene compound found in the Reishi mushroom (Ganoderma lucidum). It is extracted through ethanol or methanol extraction methods from the fruiting body of the mushroom.
Research Narrative (Provisional)
Ganoderic Acid A has been studied in vitro and in animal models for its anti-inflammatory and anti-cancer properties. Limited human trials suggest potential benefits, warranting further research.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Rich in triterpenoids with therapeutic potential. - Contains polysaccharides that support immune health. - Provides essential amino acids and vitamins.
Reported Mechanism (Provisional)
Ganoderic acid A inhibits nuclear factor-kappa B (NF-κB) signaling pathway, reducing pro-inflammatory cytokines like TNF-α and IL-6. The compound also modulates hepatic enzymes including ALT and AST while enhancing glutathione peroxidase activity for liver protection. Additionally, it stimulates macrophage activation and T-cell proliferation through Toll-like receptor modulation.
Clinical Narrative (Provisional)
Human studies on ganoderic acid A are limited, with most research conducted in animal models and in vitro studies. Rat studies have shown 30-50% reductions in liver enzyme markers at doses of 10-50mg/kg body weight. Cell culture studies demonstrate significant anti-inflammatory effects with IC50 values around 25-40 μM. More human clinical trials are needed to establish definitive therapeutic dosages and long-term safety profiles.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.